Buscar

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. Acerca de Helix Helix es la compañía líder en genómica y vigilancia viral de la población cuyas operaciones se basan en el cuidado clínico, la investigación y el análisis de datos. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Leer más About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. En virtud de los términos del acuerdo de colaboración y licencia, Gilead proporcionará fondos al Renown IHI para secuenciar y analizar el ADN de 15,000 personas que viven con EHNA o con enfermedad de hígado graso no alcohólico (EHGNA), así como de una cohorte de control de 40,000 personas en el estado de Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health es la red de atención médica más completa e integrada de Nevada y mantiene registros médicos electrónicos para 1.02 millones de pacientes registrados. En 2016, Renown Health y el Desert Research Institute crearon el Healthy Nevada Project (HNP), el primer estudio de salud poblacional basado en la comunidad del país. En 2017, el HNP comenzó una sociedad con Helix para aprovechar sus servicios de salud poblacional, la secuenciación Exome+™ y las herramientas de participación del consumidor. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. El HNP actualmente tiene 40,000 participantes. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. La EHNA es más frecuente en personas con ciertas afecciones, que incluyen obesidad y diabetes tipo 2. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead opera en más de 35 países alrededor del mundo, con sede central en Foster City, California. Para obtener más información sobre Gilead Sciences, visite el sitio web de la empresa en www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Mediante el uso de su ensayo Exome+™ de propiedad exclusiva, un exoma de tipo panel mejorado con más de 300,000 regiones no codificantes informativas, Helix ofrece a los sistemas de salud una solución escalable que permite el descubrimiento de información genética médicamente relevante y que potencialmente puede salvar vidas. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Obtenga más información en www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. Estos y otros riesgos se describen en detalle en el Informe Trimestral de Gilead en el Formulario 10-Q para el trimestre que finalizó el 31 de marzo de 2019, presentado ante la Comisión de Bolsa y Valores de los EE. UU. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Leer más About Gilead Sciences y el Renown Institute for Health Innovation anuncian una colaboración estratégica para promover la comprensión de la esteatohepatitis no alcohólica (EHNA)

New contract protects affordability for Northern Nevada Consumers. Anthem Blue Cross Blue Shield (Anthem) and Renown Health (Renown) today announced they have reached an agreement on a new contract. The agreement protects affordability and provides Anthem members with continued in-network access to all Renown hospitals and physicians. This agreement applies to Anthem consumers enrolled in employer based HMO and PPO plans and provides continued in-network access to Renown affiliated care providers and facilities. “We are pleased to continue working with Renown to maintain and improve access to healthcare for consumers and employers in Northern Nevada. Our members remained our number one priority as we worked hard and in good faith to find common ground and reach an agreement that helps achieve greater affordability,” said Mike Murphy, president, Anthem Blue Cross Blue Shield of Nevada. “We value the relationships we have with the care providers in our network, which are important to creating choices for our consumers and fulfilling our mission of improving the lives of the people in the communities we serve.” Anthony Slonim, MD, D.Ph., FACHE, President and CEO of Renown Health stated, “We appreciate the collaborative approach of both teams to reach resolution. As this community’s only not-for-profit healthcare organization, our mission is to make a genuine difference in the health and well-being of the community. As doctors, nurses and care givers, we want to ensure the greatest access, experience and highest-quality care for every member of our community including those insured by Anthem.” Consumers with questions can contact Anthem by using the toll-free number on the back of their current Anthem identification card or going to anthem.com/renown.     About Anthem Blue Cross Blue Shield: Anthem Blue Cross Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products are underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensees of the Blue Cross and Blue Shield Association. ®ANTHEM is a registered trademark of Anthem Insurance Companies, Inc. The Blue Cross and Blue Shield names and symbols are registered marks of the Blue Cross Blue Shield Association. Puede obtener información adicional sobre Anthem Blue Cross Blue Shield en Nevada en www.anthem.com. Also, follow us on Twitter @AnthemBCBS or @AnthemBCBS_News and on Facebook at Anthem Blue Cross Blue Shield.   About Renown Health: Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores de la región y cuenta con una fuerza laboral de más de 7,000 empleados. It comprises three acute care hospitals, a children’s hospital, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. For more information, visit www.renown.org.Additional Media Contacts:Mike BowmanAnthem Blue Cross Blue Shieldmichael.bowman@anthem.com916-584-6043

Leer más About Anthem Blue Cross Blue Shield y Renown Health anuncian un nuevo acuerdo contractual

Softheon and Hometown Health, Nevada's largest not-for-profit insurance company, have formed a partnership to serve Nevadans enrolling through Nevada Health Link state-based ACA marketplace. Nevada's largest not-for-profit health insurance company, Hometown Health, has entered the Affordable Care Act (ACA) marketplace and has expanded their health plan offerings through a partnership with Softheon, a leading cloud-based health insurance exchange and service provider. Softheon's innovative platform is helping bring quality health care to Nevada residents enrolling in Hometown Health insurance through Nevada Health Link. “Softheon’s expert knowledge of the ACA marketplace coupled with their leading enrollment and billing technology has made them the perfect partner during Hometown Health’s first open enrollment period on the exchange,” said David Hansen, Hometown Health CEO. “Hoy, más de 100,000 personas en Nevada eligen Hometown Health para sus necesidades de seguro. Thanks to Softheon, we look forward to expanding insurance coverage options, in a way that is simple and convenient, to our friends and families who use Nevada Health Link.” Desde el comienzo del 2021 período de inscripción abierta, más de 800 miembros nuevos se han inscrito sin problemas en el seguro de salud de Hometown Health gracias al software de vanguardia de Softheon. The partnership with Softheon will improve member enrollment, billing and communications, enabling Hometown Health to remain focused on their core mission of providing excellent healthcare to Nevada residents. As the health insurance division of Renown Health, northern Nevada’s leading healthcare provider, Hometown Health offers members competitive rates and the largest network of providers in the region. Renown Health brinda servicios médicos avanzados, que incluyen el Renown Regional Medical Center, un hospital regional de servicio completo con 808 camas; el Renown South Meadows Medical Center, un hospital comunitario de cuidados intensivos con 76 camas; el Renown Children’s Hospital, el único hospital para niños de la región con 83 camas; y el Renown Rehabilitation Hospital, un hospital de rehabilitación con 62 camas. These facilities provide quality healthcare for Renown's primary service area, Washoe County and the secondary service areas of northern Nevada and northern California. Renown Health cuenta con más de 7,000 empleados y presta servicio en el norte de Nevada, Lake Tahoe y el noreste de California, con una población total de más de 2 millones de habitantes. Además de los hospitales, Renown también cuenta con 110 consultorios del grupo médico, centros de atención de urgencia y centros de diagnóstico por imágenes para pacientes ambulatorios. Renown Health and Hometown Health offer advanced care for patients and embrace their role in improving the health and well-being of the people and communities. “The continued growth of the Affordable Care Act marketplace is welcome news for consumers who are seeking more options for accessing health coverage,” said Eugene Sayan, CEO and founder of Softheon. "We are excited to partner with Hometown Health on their entrance into the ACA marketplace to create seamless experiences for their members and connect more individuals in Nevada with quality health care.” Along with improving member enrollment, billing and communications, Softheon helps Hometown Health continue to ensure accuracy through monthly Advanced Premium Tax Credits premium reconciliation. The turnkey solution provided by Softheon has guided Hometown Health in handling all regulatory and operational requirements required of insurers in the ACA marketplace. The partnership has given Hometown Health the opportunity for expanded reach while making a bigger impact on communities across the state. Para obtener más información sobre Softheon, visite www.softheon.com. Para obtener más información sobre Hometown Health, visite www.hometownhealth.com.     Acerca de Softheon Fundada en 2000, las soluciones de software como servicio (Software-as-a-Service, SaaS) y proceso empresarial como servicio (Business Process-as-a-Service, BPaaS) de Softheon resuelven complejos desafíos para los planes de salud y las agencias gubernamentales de salud. En la actualidad, las soluciones de Softheon sirven a 8 agencias estatales y a más de 90 planes de salud. Issuers and consumers utilizing Medicaid, Medicare, and the ACA Marketplace benefit from Softheon’s innovative technology that reduces administrative overhead and enhances user-experiences. Softheon is an Agent, Broker, and Merchant of Record that facilitates health insurance enrollment, billing, and renewal.   Acerca de Hometown Health Establecida en 1988, Hometown Health es la división de seguros de Renown Health y es la compañía de seguros de salud sin fines de lucro local más grande del norte de Nevada. Providing wide-ranging medical coverage and great service to members, Hometown Health represents a philosophy of health care that emphasizes active partnerships between members and physicians. Para obtener más información, llame al 775-982-3000 o visite www.hometownhealth.com.

Leer más About Hometown Health Enters Affordable Care Act Marketplace

Anthem Blue Cross and Blue Shield Medicaid members will now have access to providers in the value-based Western Clinical Alliance, powered by Renown Health. RENO, Nev. (20 de dic. de 2021) – Los miembros de Medicaid de Anthem Blue Cross and Blue Shield en Nevada ahora pueden recibir atención de los proveedores de Western Clinical Alliance, mediante Renown Health. A first of its kind agreement, the partnership between Anthem Blue Cross and Blue Shield Medicaid and Renown Health extends care for Anthem members in northern Nevada. This agreement gives providers and patients in the region better access to care by focusing on health and well-being while reducing the overall cost of care. The Western Clinical Alliance is a value-based clinically integrated network that puts the patient at the center of care and allows collaboration between providers across the community. “The Western Clinical Alliance has been seeking this kind of innovative and forward-thinking partnership for a while, and we are excited to be working with Anthem Blue Cross and Blue Shield,” said Thomas Graf, MD, Chief Clinical and Quality Officer and Western Clinical Alliance chair. “The partnership creates an environment that eliminates many of the traditional barriers associated with providing the right care, in the right place, at the right time. For us, it is all about ensuring Anthem members have the greatest opportunity to live healthy lives; this includes their participation in preventative and wellness care as well as optimization of their chronic diseases” Western Clinical Alliance providers – including those at Renown hospitals, Renown medical groups and other community-based health organizations – have developed a relationship that makes vital data and insights readily available to better understand every patient’s journey through the healthcare system. Providers in the Western Clinical Alliance work together to drive better outcomes by helping patients receive care in the highest-value settings. “Anthem Blue Cross and Blue Shield is excited to partner with Renown Health and the Western Clinical Alliance because we believe effective health coverage begins with a trusted primary care provider who can guide our members through the complexities of the healthcare system, with an emphasis on prevention and wellness leading to better health outcomes,” said Lisa Bogard, President of Anthem Blue Cross and Blue Shield in Nevada. Muchas personas en la comunidad del norte de Nevada que están cubiertas bajo un plan de Medicaid como Anthem tendrán un plazo de inscripción abierta a partir del 1.º de enero de 2022. Además de tener la oportunidad para entablar relación con proveedores de Renown Health y Western Clinical Alliance, los miembros de Medicaid en Nevada pueden visitar www.chooseanthem.com para inscribirse en un plan que ofrece una variedad de beneficios adicionales para un buen estado físico, comidas nutritivas con entrega a domicilio, asistencia con el transporte, membresías al Boys and Girls Club, servicios de apoyo esenciales para padres primerizos y futuros padres, y más.     About Western Clinical Alliance & Renown Health Western Clinical Alliance® is a Clinically Integrated Network (CIN) which joins together physicians across our community into a single comprehensive care delivery network. The CIN is in collaboration with Renown Health and other care providers that share a common set of goals focused on increasing value by improving outcomes and better managing the total cost of care for patients. Renown Health is the region’s largest not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital and a medical group and urgent care network. Visite renown.org para obtener más información.

Leer más About Renown Health y Anthem Blue Cross and Blue Shield se asocian para extender la atención basada en el valor a miembros de Medicaid de Anthem en el norte de Nevada

Senior Care Plus llevará a cabo un seminario web gratuito diseñado para ayudar a los participantes que están por cumplir 65 años a tomar decisiones informadas sobre su cobertura médica.   Navigating the Medicare alphabet can sometimes be confusing and overwhelming, which is why the experts of locally-owned Senior Care Plus, a Medicare Advantage Plan, are hosting a free webinar on the ABCs of Medicare. There are four basic parts of Medicare: A, B, C and D. Each part helps patients pay for important healthcare services such as hospital visits, doctor visits and prescription drug coverage.   El seminario web gratuito, programado para los miércoles 5 y 19 de agosto a las 6 p.m., cubrirá los aspectos básicos de Medicare y responderá preguntas frecuentes para ayudar a los asistentes a aprovechar al máximo su cobertura médica. Both webinars will cover the same topics, however, two dates are offered as an added convenience to attendees. Visite SeniorCarePlus.com o llame al 775982-3191 para inscribirse.   “With unfamiliar words and ideas you’ve likely never come across before, learning about Medicare may feel like learning a new language at first,” said David Hansen, CEO of Hometown Health. “As you begin the process of becoming a Medicare recipient, Senior Care Plus is committed to helping you become fluent in Medicare and help you understand the basics so you can make the best decisions for your unique healthcare needs.”   From the convenience of a computer or mobile device, participants will learn about:   The parts of Medicare - A, B, C and D; Eligibility and enrollment options; How to personalize their Medicare options based on their healthcare needs   Serving as a partner in health to both northern and southern Nevadans, Senior Care Plus is the statewide leader in helping people take advantage of Medicare Advantage. Además, con ventajas para los miembros, como eventos educativos virtuales y descuentos exclusivos en recursos de salud y bienestar de vanguardia, Senior Care Plus está decidido a ayudar a sus miembros a mantenerse sanos y activos.               Para obtener más detalles sobre Senior Care Plus y sus opciones de Medicare, para asistir a una reunión informativa o para programar una consulta personal, visite seniorcareplus.com o llame al 775-982-3158.        Acerca de Hometown Health Establecida en 1988, Hometown Health es la división de seguros de Renown Health y es la compañía de seguros de salud sin fines de lucro de propiedad local más grande del norte de Nevada. Providing wide-ranging medical coverage and great service to members, Hometown Health represents a philosophy of health care that emphasizes active partnerships between members and physicians. Para obtener más información, llame al 775-982-3000 o visite hometownhealth.com.   About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Visite renown.org para obtener más información.

Leer más About Seminario web gratuito que explica los aspectos básicos de Medicare

Presented by the Desert Research Institute and Renown Health, DANA will help people learn more about the Healthy Nevada Project® and their own unique, genetic health traits What is the Healthy Nevada Project®? What are the benefits of joining this research study? How can I find out if I carry genes for health risks like heart disease, hereditary breast and ovarian cancer syndrome and Lynch syndrome? What if a holographic avatar, powered by artificial intelligence (AI), could answer all these questions and more? DANA has all the answers, she is a virtual assistant with “DNA” in her name, presented by the Renown Institute for Health Innovation (Renown IHI), a collaboration between Renown Health and the Desert Research Institute (DRI). This life-sized, holographic avatar will greet individuals outside Renown Regional Medical Center’s Sierra Café, and talk to them about the Healthy Nevada Project, the world’s largest community-based genetic population health study. Los representantes de medios de comunicación están invitados a reunirse con DANA esta mañana, desde las 10 a.m. hasta el mediodía. Responda a este correo electrónico o llame al (775) 691-7308 para coordinar una reunión. “Unfortunately, Nevada ranks among the lowest in the nation for health outcomes—and we are working to change that,” said Anthony Slonim, M.D., D.Ph., president and CEO of Renown Health and president of Renown Institute for Health Innovation. “Through the Healthy Nevada Project® , our goal is to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile. Thanks to this advanced technology, DANA will offer people a personalized explanation of the Project, and help them take the next step to better understand their health, and their health risks, so they can modify their behavior and ultimately, live a healthier, happier life.” Con más de 51,000 participantes del estudio inscritos hasta la fecha, el Healthy Nevada Project® se considera el estudio genético de más rápida inscripción del país. The Project is also the first of its kind to return clinical results to study volunteers, which means participants can learn their genetic risks tied to heart disease and certain cancers, as well as lifestyle changes that could potentially help reduce their risk and prevent disease. Furthermore, participants can choose to share their information with their medical provider to improve and enhance their medical care. “We are always happy to engage with our study participants and look forward to having them meet and engage with DANA,” said Joseph Grzymski, Ph.D., research professor at DRI, principal investigator of the Healthy Nevada Project® and chief scientific officer for Renown Health. “At a time of physical distancing and limiting human contact where possible, using tools like an avatar and AI are important for communicating, whether it be for genetics, vaccinations or other important health information.” Visitors can interact with DANA through a touch screen (cleaned and sanitized after every encounter) to learn more about the study, enter their contact information and schedule an appointment to join the free genetics study or receive more information about their test results. Kiosk visitors are asked to maintain physical distance guidelines and use the hand sanitizer and Sani Wipes available next to the kiosk.     Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org.

Leer más About Presentación de Dana, el nuevo quiosco holográfico tamaño real del Renown Institute for Health Innovations

David Hansen, MBA, joins Hometown Health to continue to serve future generations and improve the health and well-being of Nevadans Renown Health and Hometown Health are excited to announce David Hansen, MBA, is joining Hometown Health as its Chief Executive Officer (CEO). In his role as CEO, Hansen will oversee Hometown Health, contributing to its growth to ensure the not-for-profit company is here for generations to come and to assist Renown in developing new care models that will deliver healthcare that is both accessible and affordable. “We are pleased to welcome such an experienced and talented leader like David to our organization and to northern Nevada,” said Tony Slonim, MD, D.Ph., President and CEO, Renown Health. “Como director ejecutivo de Hometown Health, David seguirá fomentando una cultura de cuidado y excelencia, y, a la vez, garantizará una amplia cobertura médica y un excelente servicio al cliente a los más de 138,000 miembros de Hometown Health en todo el estado”. Hansen has spent the previous twenty years of his career working for UnitedHealthcare, a health insurance company based out of Minnetonka, Minnesota. During his time at UnitedHealthcare, Hansen held various roles including chief financial officer of clinical & network services, west region president of network & provider services, chief executive officer of the California Health Plan and chief executive officer of the Pacific Northwest Health Plan. He has also served in executive roles with PacifiCare and TransAmerica Occidental Life and began his career in the audit and management consulting practice of Deloitte & Touche. “Choosing healthcare coverage is one of the most important decisions people make. I am excited to begin my work with Hometown Health and Renown to help our members receive the quality coverage to enhance their health and well-being,” said Hansen. “Hometown Health is such a community-focused organization and I look forward to being a part of a team that gives back to improve the health and wellbeing of the communities we serve. ”David has an MBA in Finance and Business Policy from the University of Chicago, and a BA in Economics and Business from the University of California, Los Angeles.     Acerca de Hometown Health Establecida en 1988, Hometown Health es la división de seguros de Renown Health y es la compañía de seguros de salud sin fines de lucro de propiedad local más grande del norte de Nevada. Providing wide-ranging medical coverage and great service to members, Hometown Health represents a philosophy of health care that emphasizes active partnerships between members and physicians. Para obtener más información, llame al 775-982-3000 o visite www.hometownhealth.com. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Visite renown.org para obtener más información.

Leer más About Hometown Health, la compañía de seguros sin fines de lucro de propiedad local más grande de la región, da la bienvenida a su nuevo director ejecutivo

El enfoque basado en la comunidad del Healthy Nevada Project revela que hasta un 90 % de los riesgos de padecer afecciones genéticas de Nivel 1 de los CDC no se detecta cuando se usan pautas de atención clínica. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. En 2018, el Healthy Nevada Project® (el mayor estudio de salud poblacional basado en la comunidad que combina datos genéticos, clínicos, ambientales y sociales) comenzó a notificarles a los participantes del estudio que habían dado su consentimiento sobre ciertas variantes genéticas que los predisponían a padecer las afecciones genéticas de Nivel 1 de los Centros para el Control y la Prevención de Enfermedades (Centers for Disease Control and Prevention, CDC). The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Los resultados iniciales de casi 27,000 participantes del estudio mostraron que el 90 % de los portadores de las afecciones genéticas de Nivel 1 de los CDC no había sido previamente identificado en un entorno clínico. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Del grupo de 26,906 participantes del Healthy Nevada Project® que el equipo de investigación de Grzymski estudió, 358 (el 1.33 %) eran portadores de afecciones de Nivel 1 de los CDC. Sin embargo, solo el 25 % de esas personas cumplían las pautas clínicas para realizarse exámenes de detección genética. Además, más del 20 % de los portadores ya tenía un diagnóstico de enfermedad relacionada con la afección genética subyacente. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” En particular, el estudio descubrió que de los 273 participantes que eran portadores de las afecciones genéticas de Nivel 1 de los CDC y que tenían información de registros clínicos, solo 22 personas mostraron sospechas previas de tener estas afecciones genéticas subyacentes. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. El Healthy Nevada Project®, que se lanzó en 2016, ofrece pruebas genéticas gratuitas a todos los residentes de Nevada, mayores de 18 años, interesados en obtener más información sobre su salud y perfil genético. Con más de 50,000 participantes del estudio inscritos en cuatro años, el Healthy Nevada Project® se ha convertido en el estudio genético de más rápida inscripción del mundo. For more about the Healthy Nevada Project® please visit healthynv.org     Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Obtenga más información en www.helix.com.

Leer más About Los exámenes de detección genética poblacionales demuestran que identifican de manera eficiente un aumento en el riesgo de padecer enfermedades hereditarias